Top Markets
#1 DeFiChain DeFiChain +2,516.54%
#2 Akedo Akedo +207.46%
#3 ONFA ONFA +54.25%
#4 Metaplex Metaplex +23.40%
#5 Osaka Protocol Osaka Protocol +21.73%
#6 Talus Network Talus Network +20.44%
#7 Wrapped Krown Wrapped Krown +20.00%
#8 DODO DODO +17.78%
#9 Black Phoenix Black Phoenix +15.09%
#10 eCash eCash +13.30%
Coin of the day
DeFiChain DeFiChain
設定
言語
日本
通貨
USD
テーマ
Valbiotis SA Valbiotis SA

Valbiotis SA

ALVAL
株式のランク #16315
Valbiotis SA engages in the research and development of health nutrition... Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.
株価
$0.94180721
時価総額
$22.26M
変化（1日）
0.38%
変化（1年）
-14.35%
国
FR
取引 Valbiotis SA (ALVAL)

カテゴリー

Healthcare
Valbiotis SA（ALVAL）の発行済株式数
December 2025 時点の発行済株式数 23.69M
Valbiotis SA の最新の財務報告および株価によると、現在の発行済株式数は 23.69M です。December 2023 の終わりには、同社は 12.46M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Valbiotis SA（ALVAL）の発行済株式数の履歴（2015 ～ 2026）
各年末時点の発行済株式数
年 発行済株式数 変化
2026 (TTM) 23.69M 50.02%
2024 15.79M 26.74%
2023 12.46M 23.21%
2022 10.11M 10.45%
2021 9.16M 22.88%
2020 7.45M 58.63%
2019 4.70M 24.66%
2018 3.77M 42.50%
2017 2.64M -26.12%
2016 3.58M 29,318.19%
2015 12.17K 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数 差 国
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.44B 18,649.65%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 254.10M 972.42%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 104.00M 338.93%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 701.88%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M 159.22%
NL